Details of the Drug

General Information of Drug (ID: DMWKDOQ)

Drug Name
MRX34
Indication
Disease Entry ICD 11 Status REF
Liver cancer 2C12 Phase 1 [1]
Cross-matching ID
TTD ID
D08SJY

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
microRNA hsa-miR-34 (MIR34) TT96IGO NOUNIPROTAC Modulator [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT01829971) A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection. U.S. National Institutes of Health.
2 Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.